TMTomofumi Miura

Tomofumi Miura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tomofumi Miura has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neurocognitive profile of euthymic Japanese patients with bipolar disorder

    by Nozomi Ishisaka, Satomi Shimano, Tomofumi Miura, Keisuke Motomura, Machiko Horii, Hisako Imanaga, Junji Kishimoto, Yasuhiro Kaneda, Ichiro Sora, Shigenobu Kanba

    Aim: Neurocognitive impairment is one of the core symptoms of bipolar disorder (BD). The MATRICS Cognitive Consensus Battery (MCCB) is a potential consensus assessment tool to evaluate cognitive function in patients with BD. Here, we report on cognitive deficits evaluated using the MCCB Japanese version (MCCB‐J) in euthymic Japanese patients with BD, and compare them with scores in previous studies.Methods: We compared neurocognitive function in 25 patients with euthymic BD and 53 healthy controls (HC). Additionally, we searched all available databases for studies that have evaluated cognitive function in BD using the MCCB, and conducted a meta‐analysis.Results: Canonical discriminant analysis revealed significant differences in MCCB‐J domain scores between BD and HC. Patients with BD performed significantly worse on visual learning, social cognition, speed of processing, and MCCB composite scores. Our meta‐analysis revealed that patients with BD performed worse than HC, as reflected by MCCB composite scores and scores on all seven cognitive domains. However, there are differences in the cognitive deficits identified in previous studies compared with our participants, particularly social cognition.Conclusion: As reported in previous studies, neurocognitive deficits were observed in Japanese euthymic BD patients assessed using the MCCB‐J. Further study is needed to clarify whether differences in social cognition between this study and previous studies are a result of coping mechanisms for social settings in Japanese populations.


  • Open Access

    Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review

    by Toshi A. Furukawa, Tomofumi Miura, Anna Chaimani, Stefan Leucht, Andrea Cipriani, Hisashi Noma, Hiroshi Mitsuyasu, Shegenobu Kanba, Georgia Salanti

    Limitations in the primary studies constitute one important factor to be considered in the grading of recommendations assessment, development, and evaluation (GRADE) system of rating quality of evidence. However, in the network meta-analysis (NMA), such evaluation poses a special challenge because each network estimate receives different amounts of contributions from various studies via direct as well as indirect routes and because some biases have directions whose repercussion in the network can be complicated. In this report we use the NMA of maintenance pharmacotherapy of bipolar disorder (17 interventions, 33 studies) and demonstrate how to quantitatively evaluate the impact of study limitations using netweight, a STATA command for NMA. For each network estimate, the percentage of contributions from direct comparisons at high, moderate or low risk of bias were quantified, respectively. This method has proven flexible enough to accommodate complex biases with direction, such as the one due to the enrichment design seen in some trials of bipolar maintenance pharmacotherapy. Using netweight, therefore, we can evaluate in a transparent and quantitative manner how study limitations of individual studies in the NMA impact on the quality of evidence of each network estimate, even when such limitations have clear directions.


  • Bipolar treatment efficacy – Authors' reply

    by Tomofumi Miura, Toshi A Furukawa, Andrea Cipriani, Keisuke Motomura, Hiroshi Mitsuyasu, Shiro Tanaka, Stefan Leucht, Satomi Shimano-Katsuki, Georgia Salanti, Hisashi Noma, et al.

  • Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis

    by Tomofumi Miura, Hisashi Noma, Toshi A Furukawa, Hiroshi Mitsuyasu, Shiro Tanaka, Sarah Stockton, Georgia Salanti, Keisuke Motomura, Satomi Shimano-Katsuki, Stefan Leucht, et al.


    • 1 January 2014
      • Vol. 116  (9) , 735-45

    [Adverse drug reactions of psychotropic agents: adverse drug reactions and safety monitoring of psychotropic agents].

    by Tomofumi Miura, Shoichiro Nakanishi, Shigenobu Kanba, Hiroyuki Uchida, Takeo Saio, Eiji Suzuki, Yutaro Suzuki, Keisuke Takahashi, Atsuo Nakagawa, Masahiko Mikuni, et al.

    Pharmacological treatments of psychiatric illness have been developed and many psychotropic drugs are now on the market. The body of safety information regarding psychotropic agents is so large that it is difficult for clinicians to consider all the details of possible adverse drug reactions(ADRs) in daily clinical practice. Although it is impossible to predict and prevent all occurrences of ADRs, many of them may be preventable. In this context, there is a strong need for compact manuals of diagnosis and treatment for ADRs arising from psychotropic agents that are likely to be used in daily practice. Under the auspices of the Japanese Society of Psychiatry and Neurology, a task force was convened to answer this need. This review focuses on the general considerations of ADRs with psychotropic agents, based on discussions of the task force. We also discuss the guidelines for drug safety monitoring, targeted towards specific psychiatric disorders or patients taking specific classes of drugs. Finally, we introduce the Adverse Drug Reactions Relief System in Japan.